Hiemstra, Ida H ; Santegoets, Kim C.M ; Janmaat, Maarten L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320249/.  , 2023

Verkleij, Christie P.M ; Frerichs, Kristine A ; Broekmans, Marloes E.C...
https://research.rug.nl/en/publications/f4115bfc-b10e-4728-8dbf-d87f2c59db7e.  , 2023

Verkleij, Christie P.M ; Frerichs, Kristine A ; Broekmans, Marloes E.C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155898/.  , 2023

Frerichs, Kristine ; Verkleij, Christie ; Mateos, Maria-Victoria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429903/.  , 2023

Frerichs, Kristine A ; Minnema, Monique C ; Levin, Mark-David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153006/.  , 2021

Frerichs, Kristine A ; Minnema, Monique C ; Levin, Mark David...
Frerichs , K A , Minnema , M C , Levin , M D , Broijl , A , Bos , G M J , Kersten , M J , Mutis , T , Verkleij , C P M , Nijhof , I S , Maas-Bosman , P W C , Klein , S K , Zweegman , S , Sonneveld , P & Van de Donk , N W C J 2021 , ' Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma ' , Blood advances , vol. 5 , no. 23 , pp. 5128-5139 . https://doi.org/10.1182/bloodadvances.2021005220.  , 2021

Hosny, Mashhour ; Verkleij, Christie P. M ; van der Schans, Jort...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509238/.  , 2021

Frerichs, Kristine A ; Minnema, Monique C ; Levin, Mark David...
https://research.rug.nl/en/publications/3cde8b28-4c34-4657-8ec8-005d1cb1caec.  , 2021

Verkleij, Christie P. M ; Broekmans, Marloes E. C ; van Duin, Mark...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095149/.  , 2021

Katsarou, Afroditi ; Sjöstrand, Maria ; Naik, Jyoti...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869449/.  , 2021

Verkleij, Christie P. M ; Broekmans, Marloes E. C ; van Duin, Mark...
Verkleij , C P M , Broekmans , M E C , van Duin , M , Frerichs , K A , Kuiper , R , de Jonge , A V , Kaiser , M , Morgan , G , Axel , A , Boominathan , R , Sendecki , J , Wong , A , Verona , R I , Sonneveld , P , Zweegman , S , Adams , H C , Mutis , T & van de Donk , N W C J 2021 , ' Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma ' , Blood , vol. 5 , no. 8 , pp. 2196-2215 . https://doi.org/10.1182/BLOODADVANCES.2020003805.  , 2021

Frerichs, Kristine A ; Verkleij, Christie P. M ; Dimopoulos, Meletios A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158123/.  , 2021

Frerichs, Kristine A ; Minnema, Monique C ; Levin, Mark-David...
Frerichs , K A , Minnema , M C , Levin , M-D , Broijl , A , Bos , G M J , Kersten , M J , Mutis , T , Verkleij , C P M , Nijhof , I S , Maas-Bosman , P W C , Klein , S K , Zweegman , S , Sonneveld , P & van de Donk , N W C J 2021 , ' Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma ' , Blood , vol. 5 , pp. 5128-5139 . https://doi.org/10.1182/bloodadvances.2021005220.  , 2021

Verkleij, Christie P.M ; Frerichs, Kristine A ; Broekmans, Marloes...
Verkleij , C P M , Frerichs , K A , Broekmans , M , Absalah , S , Maas-Bosman , P W C , Kruyswijk , S , Nijhof , I S , Mutis , T , Zweegman , S & van de Donk , N W C J 2020 , ' T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma ' , Oncotarget , vol. 11 , no. 45 , pp. 4076-4081 . https://doi.org/10.18632/oncotarget.27792.  , 2020

Frerichs, Kristine A ; Broekmans, Marloes E. C ; Marin Soto, Jhon A...
Frerichs , K A , Broekmans , M E C , Marin Soto , J A , van Kessel , B , Heymans , M W , Holthof , L C , Verkleij , C P M , Boominathan , R , Vaidya , B , Sendecki , J , Axel , A , Gaudet , F , Pillarisetti , K , Zweegman , S , Adams , H C , Mutis , T , van de Donk , N W C J & van de Donk , N W C J 2020 , ' Preclinical Activity of JNJ-7957, a Novel BCMA ×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab ' , Clinical cancer research : an official journal of the American Association for Cancer Research , vol. 26 , no. 9 , pp. 2203-2215 . https://doi.org/10.1158/1078-0432.CCR-19-2299.  , 2020